These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22293638)

  • 1. Oxytocin administration: the transition to a safer model of care.
    Krening CF; Rehling-Anthony K; Garko C
    J Perinat Neonatal Nurs; 2012; 26(1):15-24. PubMed ID: 22293638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxytocin administration: the transition to a safer model of care.
    Krening CF; Rehling-Anthony K; Garko C
    J Perinat Neonatal Nurs; 2012; 26(1):25-6. PubMed ID: 22293639
    [No Abstract]   [Full Text] [Related]  

  • 3. Oxytocin, excessive uterine activity, and patient safety: time for a collaborative approach.
    Miller LA
    J Perinat Neonatal Nurs; 2009; 23(1):52-8. PubMed ID: 19209060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxytocin as a high-alert medication: implications for perinatal patient safety.
    Simpson KR; Knox GE
    MCN Am J Matern Child Nurs; 2009; 34(1):8-15; quiz 16-7. PubMed ID: 19104313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving patient safety and uniformity of care by a standardized regimen for the use of oxytocin.
    Hayes EJ; Weinstein L
    Am J Obstet Gynecol; 2008 Jun; 198(6):622.e1-7. PubMed ID: 18355786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of a conservative checklist-based protocol for oxytocin administration: maternal and newborn outcomes.
    Clark S; Belfort M; Saade G; Hankins G; Miller D; Frye D; Meyers J
    Am J Obstet Gynecol; 2007 Nov; 197(5):480.e1-5. PubMed ID: 17980181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for oxytocin administration after birth: AWHONN practice brief number 2.
    J Obstet Gynecol Neonatal Nurs; 2015; 44(1):161-163. PubMed ID: 25421530
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of orally administered misoprostol to intravenous oxytocin for labor induction in women with favorable cervical examinations.
    Wing DA; Fassett MJ; Guberman C; Tran S; Parrish A; Guinn D
    Am J Obstet Gynecol; 2004 Jun; 190(6):1689-94; discussion 1694-6. PubMed ID: 15284771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy and safety of vaginal misoprostol versus dinoprostone vaginal insert in labor induction at term: a randomized trial.
    Ozkan S; Calişkan E; Doğer E; Yücesoy I; Ozeren S; Vural B
    Arch Gynecol Obstet; 2009 Jul; 280(1):19-24. PubMed ID: 19034471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxytocin Use in Labor: Legal Implications.
    Drummond S
    J Perinat Neonatal Nurs; 2018; 32(1):34-42. PubMed ID: 29240650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A performance improvement process to tackle tachysystole.
    Doyle J; Kenny TH; Burkett AM; von Gruenigen VE
    J Obstet Gynecol Neonatal Nurs; 2011; 40(5):512-9. PubMed ID: 22273408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Best practices in perinatal care: evidence-based management of oxytocin induction and augmentation of labor.
    Mahlmeister LR
    J Perinat Neonatal Nurs; 2008; 22(4):259-63. PubMed ID: 19011488
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized trial comparing vaginal misoprostol versus Foley catheter with concurrent oxytocin for labor induction in nulliparous women.
    Culver J; Strauss RA; Brody S; Dorman K; Timlin S; McMahon MJ
    Am J Perinatol; 2004 Apr; 21(3):139-46. PubMed ID: 15085496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxytocin safety: legal implications for perinatal nurses.
    Pearson N
    Nurs Womens Health; 2011; 15(2):110-7. PubMed ID: 21504545
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinicians' guide to the use of oxytocin for labor induction and augmentation.
    Simpson KR
    J Midwifery Womens Health; 2011; 56(3):214-21. PubMed ID: 21535370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective randomized study comparing misoprostol and oxytocin for premature rupture of membranes at term.
    Zeteroğlu S; Engin-Ustün Y; Ustün Y; Güvercinçi M; Sahin G; Kamaci M
    J Matern Fetal Neonatal Med; 2006 May; 19(5):283-7. PubMed ID: 16753768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of low-dose oxytocin and dinoprostone for labor induction in postterm pregnancies: a randomized controlled prospective study.
    Akay NÖ; Hızlı D; Yılmaz SS; Yalvaç S; Kandemir O
    Gynecol Obstet Invest; 2012; 73(3):242-7. PubMed ID: 22433939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High- versus low-dose oxytocin for augmentation or induction of labor.
    Patka JH; Lodolce AE; Johnston AK
    Ann Pharmacother; 2005 Jan; 39(1):95-101. PubMed ID: 15572602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of labor with oxytocin increases cesarean section rate as compared with oxytocin for augmentation of spontaneous labor in nulliparous parturients controlled for lumbar epidural analgesia.
    Kaul B; Vallejo MC; Ramanathan S; Mandell G; Phelps AL; Daftary AR
    J Clin Anesth; 2004 Sep; 16(6):411-4. PubMed ID: 15567643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
    Ramsey PS; Savage K; Lincoln T; Owen J
    Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.